Search Results - Johannes R. Hov

Refine Results
  1. 1
    The gut microbial influence on cholestatic liver disease

    The gut microbial influence on cholestatic liver disease by Martin Kummen, Johannes R. Hov

    Published 2019
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    The Microbiome in Primary Sclerosing Cholangitis: Current Evidence and Potential Concepts

    The Microbiome in Primary Sclerosing Cholangitis: Current Evidence and Potential Concepts by Johannes R. Hov, Tom H. Karlsen

    Published 2017
    Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Autoantibodies in primary sclerosing cholangitis

    Autoantibodies in primary sclerosing cholangitis by Johannes R. Hov, Kirsten Muri Boberg, Tom H. Karlsen

    Published 2008
    Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions

    The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions by Marius Trøseid, Geir Øystein Andersen, Kaspar Broch, Johannes R. Hov

    Published 2020
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    Major Increase in Microbiota-Dependent Proatherogenic Metabolite TMAO One Year After Bariatric Surgery

    Major Increase in Microbiota-Dependent Proatherogenic Metabolite TMAO One Year After Bariatric Surgery by Marius Trøseid, Johannes R. Hov, Torunn Kristin Nestvold, Hanne Thoresen, Rolf K. Berge, Asbjørn Svardal, Knut Tore Lappegård

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation

    The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation by Tarek Mazzawi, Gülen Arslan Lied, Dag A. Sangnes, Magdy El‐Salhy, Johannes R. Hov, Odd Helge Gilja, Jan Gunnar Hatlebakk, Trygve Hausken

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Circulating markers of gut barrier function associated with disease severity in primary sclerosing cholangitis

    Circulating markers of gut barrier function associated with disease severity in primary sclerosing cholangitis by Amandeep K. Dhillon, Martin Kummen, Marius Trøseid, Sissel Åkra, Evaggelia Liaskou, Bjørn Moum, Mette Vesterhus, Tom H. Karlsen, Ingebjørg Seljeflot, Johannes R. Hov

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Association Between HLA Haplotypes and Increased Serum Levels of IgG4 in Patients With Primary Sclerosing Cholangitis

    Association Between HLA Haplotypes and Increased Serum Levels of IgG4 in Patients With Primary Sclerosing Cholangitis by Natalie Lie Berntsen, Olav Klingenberg, Brian D. Juran, M Valle, Björn Lindkvist, Konstantinos N. Lazaridis, Kirsten Muri Boberg, Tom H. Karlsen, Johannes R. Hov

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels

    Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota compositio... by Tarek Mazzawi, Trygve Hausken, Johannes R. Hov, Jørgen Valeur, Dag A. Sangnes, Magdy El‐Salhy, Odd Helge Gilja, Jan Gunnar Hatlebakk, Gülen Arslan Lied

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Increased Secondary/Primary Bile Acid Ratio in Chronic Heart Failure

    Increased Secondary/Primary Bile Acid Ratio in Chronic Heart Failure by Cristiane C.K. Mayerhofer, Thor Ueland, Kaspar Broch, Royce P Vincent, Gemma F. Cross, Christen P. Dahl, Pål Aukrust, Lars Gullestad, Johannes R. Hov, Marius Trøseid

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Characterization of Intestinal Microbiota in Ulcerative Colitis Patients with and without Primary Sclerosing Cholangitis

    Characterization of Intestinal Microbiota in Ulcerative Colitis Patients with and without Primary Sclerosing Cholangitis by David Kevans, Andrea D. Tyler, Kristian Holm, Kristin Kaasen Jørgensen, M H Vatn, Tom H. Karlsen, Gilaad G. Kaplan, Bertus Eksteen, Dirk Gevers, Johannes R. Hov, Mark S. Silverberg

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    High‐throughput T‐cell receptor sequencing across chronic liver diseases reveals distinct disease‐associated repertoires

    High‐throughput T‐cell receptor sequencing across chronic liver diseases reveals distinct disease‐associated repertoires by Evaggelia Liaskou, Eva Henriksen, Kristian Holm, Fatemeh Kaveh, David Hamm, Janine Fear, Marte K. Viken, Johannes R. Hov, Espen Melum, Harlan Robins, Johanna Olweus, Tom H. Karlsen, Gideon M. Hirschfield

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Electrostatic modifications of the human leukocyte antigen‐DR P9 peptide‐binding pocket and susceptibility to primary sclerosing cholangitis

    Electrostatic modifications of the human leukocyte antigen‐DR P9 peptide‐binding pocket and susceptibility to primary sclerosing cholangitis by Johannes R. Hov, Vasilis Kosmoliaptsis, James A. Traherne, Marita Olsson, Kirsten Muri Boberg, Annika Bergquist, Erik Schrumpf, Andrew Bradley, Craig J. Taylor, Benedicte A. Lie, John Trowsdale, Tom H. Karlsen

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Intestinal fatty acid binding protein is associated with cardiac function and gut dysbiosis in chronic heart failure

    Intestinal fatty acid binding protein is associated with cardiac function and gut dysbiosis in chronic heart failure by Andraž Nendl, Sajan C. Raju, Kaspar Broch, Cristiane C.K. Mayerhofer, Kristian Holm, Bente Halvorsen, Knut Tore Lappegård, Samuel Datum Moscavitch, Johannes R. Hov, Ingebjørg Seljeflot, Marius Trøseid, Ayodeji Awoyemi

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Development of a high-resolution NGS-based HLA-typing and analysis pipeline

    Development of a high-resolution NGS-based HLA-typing and analysis pipeline by M. Wittig, Jarl Andreas Anmarkrud, Jan Christian Kässens, Sebastian Koch, Michael Förster, Eva Ellinghaus, Johannes R. Hov, Sascha Sauer, Manfred Schimmler, Malte Ziemann, S. Görg, F Jacob, Tom H. Karlsen, André Franke

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    The gut microbiota contributes to a mouse model of spontaneous bile duct inflammation

    The gut microbiota contributes to a mouse model of spontaneous bile duct inflammation by E. Schrumpf, Martin Kummen, Laura Valestrand, Thomas U. Greiner, Kristian Holm, Velmurugesan Arulampalam, Henrik M. Reims, John F. Baines, Fredrik Bäckhed, Tom H. Karlsen, Richard S. Blumberg, Johannes R. Hov, Espen Melum

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Gut Microbiota Alterations and Circulating Imidazole Propionate Levels Are Associated With Obstructive Coronary Artery Disease in People With HIV

    Gut Microbiota Alterations and Circulating Imidazole Propionate Levels Are Associated With Obstructive Coronary Artery Disease in People With HIV by Marius Trøseid, Antonio Molinaro, Marco Gelpi, Beate Vestad, Klaus F. Kofoed, Andreas Fuchs, Lars Køber, Kristian Holm, Thomas Benfield, Per Magne Ueland, Johannes R. Hov, Susanne Dam Nielsen, Andreas Dehlbæk Knudsen

    Published 2024
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Design of the GutHeart—targeting gut microbiota to treat heart failure—trial: a Phase II, randomized clinical trial

    Design of the GutHeart—targeting gut microbiota to treat heart failure—trial: a Phase II, randomized clinical trial by Cristiane C.K. Mayerhofer, Ayodeji Awoyemi, Samuel Datum Moscavitch, Knut Tore Lappegård, Johannes R. Hov, Pål Aukrust, Anders Hovland, Andrea De Lorenzo, Sigrun Halvorsen, Ingebjørg Seljeflot, Lars Gullestad, Marius Trøseid, Kaspar Broch

    Published 2018
    Get full text
    Revisão
    Save to List
    Saved in:
  19. 19
    The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls

    The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls by Martin Kummen, Kristian Holm, Jarl Andreas Anmarkrud, Ståle Nygård, Mette Vesterhus, Marte Lie Høivik, Marius Trøseid, Hanns‐Ulrich Marschall, Erik Schrumpf, Bjørn Moum, Helge Røsjø, Pål Aukrust, Tom H. Karlsen, Johannes R. Hov

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Microbiota‐dependent metabolite trimethylamine‐N‐oxide is associated with disease severity and survival of patients with chronic heart failure

    Microbiota‐dependent metabolite trimethylamine‐N‐oxide is associated with disease severity and survival of patients with chronic heart failure by Marius Trøseid, Thor Ueland, Johannes R. Hov, Asbjørn Svardal, Ida Gregersen, C. P. Dahl, Svend Aakhus, Einar Gude, Bodil Bjørndal, Bente Halvorsen, Tom H. Karlsen, Pål Aukrust, Lars Gullestad, Rolf K. Berge, Arne Yndestad

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: